PCI Pharma Services hosted an official visit by the UK Government to its US Headquarters in Philadelphia, Pennsylvania this week.

Led by Secretary of State for Wales and UK Board of Trade Advisor Alun Cairns, the visit was part of a trade mission to attract US businesses to invest in Wales and build on a commercial relationship already worth more than $46 billion. PCI was chosen as a host for the UK Government’s Trade Mission visit in recognition of its long-standing relationship with Wales, where they currently employ over 600 people.

During the three-day visit to New York, New Jersey and Pennsylvania, Mr. Cairns met with representatives from innovative pharmaceutical and biotechnology sectors, as well as other sectors including cyber security.

The Secretary of State said, “Wales and the United States are close trading partners – and I want to ensure that we continue to build on this important relationship by creating more investment and exporting opportunities for companies from both countries.”

PCI Pharma Services president and chief executive officer Bill Mitchell, said: “We were delighted to welcome the UK Government delegation to our Philadelphia site. It was an exceptional  opportunity to showcase our market-leading outsourced manufacturing, packaging and logistical services for the global healthcare industry. The visit pays great testimony to our US operations, but also our ongoing commitment to our EU operations. Our Welsh sites play a very important part in delivering on our strategy to be the partner of choice for pharmaceutical and biotech companies to bring lifesaving medicines to patients around the world.”

PCI recently announced its newly expanded European Clinical Services Center of Excellence at Bridgend, along with the expansion of its European Manufacturing Center of Excellence at Tredegar. Both site expansions were part of an ongoing investment program to increase capacity and capability across PCI’s Welsh sites.